Executive Incentives Through Stock Options
First written in FY2016. 4 of 9 entries say "Advanced", first in FY2017-Q2. Latest entry: FY2025.
- FY2025RestatedAnnual report
「For stock options outstanding during the consolidated fiscal year, the number of stock options is stated on a share-equivalent basis.」
The unexercised balance of stock options for directors continues to be disclosed, with no new grants or exercises during the period reported. - FY2023RestatedAnnual report
「For stock options outstanding during the consolidated fiscal year … Unexercised balance … Common shares: 14,000 … 12,000 … 62,400」
The unexercised balance of stock options for directors continues to be disclosed. No new grants or exercises during the period are reported. - FY2021RestatedAnnual report
「Unexercised balance 14,000 12,000 62,400」
The unexercised balance of stock options for directors from the 11th through 13th series continues to be disclosed. No exercises or new grants during the period are reported. - FY2020-Q2AdvancedAnnual report
「13th series of subscription rights to shares (resolution of the Board of Directors dated 10 July 2019 based on the resolution of the annual general meeting of shareholders held on 23 June 2011) … Number of subscription rights to shares: 624 … Class, details and number of shares underlying the subscription rights … Common shares: 62,400 … Exercise period*: 12 July 2019 to 11 July 2044」
The specific issue details and exercise period were disclosed for the stock options for directors approved in the previous fiscal year, comprising 624 rights covering 62,400 shares. - FY2019AdvancedAnnual report
「At a meeting of the Board of Directors held on 22 June 2019, the Company resolved, pursuant to the Companies Act, to issue subscription rights to shares to its directors as equity compensation-type stock options.」
The issuance of the 13th series of subscription rights to shares was approved for 3 directors, comprising 625 rights covering 62,500 shares, advancing the operation of the executive incentive scheme. - FY2018RestatedAnnual report
「For stock options outstanding during the consolidated fiscal year, 7,000 shares were exercised on 10 July 2015 and 6,000 shares were exercised on 13 July 2016.」
Annual disclosure is provided on the exercise of executive stock options, but there were no new grants during the fiscal year, and the disclosure only confirms the operation of the existing scheme. - FY2018-Q1AdvancedAnnual report
「The increase in stated capital resulted from the exercise of subscription rights to shares (stock options).」
The exercise of subscription rights to shares increased the number of shares by 59,800 during the first quarter, confirming the exercise of previously issued stock options. - FY2017-Q2AdvancedAnnual report
「Stock acquisition rights issued during the second-quarter accounting period were as follows.」
Subscription rights to shares for directors were actually issued. The issue comprised 180 rights covering 18,000 shares, with an exercise period from 15 July 2016 to 14 July 2041. - FY2016First statedAnnual report
「The Company grants stock options as compensation linked to an increase in enterprise value, with the aim of reflecting performance over the medium to long term.」
The Company granted equity compensation-type stock options to directors, with an exercise period from July 2016 to July 2041.